ARTICLE | Clinical News
CybroCell: Ph I started
February 1, 2017 9:45 PM UTC
SpinalCyte began a double-blind, saline-controlled, Mexican Phase I trial to evaluate CybroCell alone or in combination with platelet-rich plasma in about 18 patients....
BCIQ Company Profiles